Content related to Finding New Combination Therapies for Neuroblastoma

A recent study found that the growth factor G-CSF, used in high-risk neuroblastoma treatment, leads to increased tumor growth and metastasis. Investigators think the benefits still outweigh the risks.

Neuroblastoma cells under a microscope labeled with fluorescent molecules. Image courtesy of Shutterstock. Building upon more than two decades of basic research conducted at Children’s Hospital Los

Yves De Clerck, MD

Investigators at The Saban Research Institute of Children’s Hospital Los Angeles have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma

Children’s Hospital Los Angeles is the only hospital in Southern California where patients can receive MIBG therapy, a specialized targeted radiation therapy for neuroblastoma.

Ella and her family moved from the East Coast to Southern California in search of the best treatment for high-risk neuroblastoma—and found it at Children’s Hospital Los Angeles.